Akero Therapeutics (AKRO) Stock Chart & Stock Price History → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free AKRO Stock Alerts $18.82 +0.51 (+2.79%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Akero Therapeutics Stock Price Performance5 Day Performance+2.73%1 Month Performance-5.38%3 Month Performance-30.27%6 Month Performance+12.43%Year-To-Date Performance-19.40%1 Year Performance-57.78% Receive AKRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Akero Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad The Freeport SocietyBiden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. AKRO Stock Chart for Saturday, June, 1, 2024 AKRO Chart by TradingView Akero Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$18.31$18.82+2.79%$19.06$18.16729,466 shs$1.30 billion05/30/2024$18.66$18.31-1.88%$19.12$18.10993,437 shs$1.27 billion05/29/2024$19.50$18.66-4.31%$19.38$18.53568,944 shs$1.29 billion05/28/2024$18.32$19.50+6.44%$19.55$18.021.01 million shs$1.35 billion05/27/2024$18.32$18.32$19.05$17.88993,400 shs$1.27 billion05/24/2024$18.91$18.32-3.12%$19.05$17.88993,399 shs$1.27 billion Get the Latest News and Ratings for AKRO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$20.50$18.91-7.76%$20.47$18.38963,874 shs$1.31 billion05/22/2024$20.24$20.50+1.28%$20.87$19.94633,350 shs$1.42 billion05/21/2024$20.14$20.24+0.50%$20.53$19.95434,778 shs$1.40 billion05/20/2024$19.92$20.14+1.10%$20.35$19.82577,856 shs$1.39 billion05/17/2024$20.73$19.92-3.91%$20.82$19.76457,660 shs$1.38 billion05/16/2024$21.07$20.73-1.61%$21.10$20.33457,700 shs$1.43 billion05/15/2024$20.30$21.07+3.79%$21.74$20.49520,273 shs$1.46 billion05/14/2024$20.62$20.30-1.55%$21.51$20.27610,023 shs$1.40 billion05/13/2024$19.65$20.62+4.94%$21.46$19.46567,628 shs$1.43 billion05/10/2024$20.80$19.65-5.53%$21.45$19.59567,401 shs$1.36 billion05/09/2024$21.02$20.80-1.05%$21.21$20.54414,266 shs$1.44 billion05/08/2024$22.02$21.02-4.54%$21.91$20.58581,020 shs$1.45 billion05/07/2024$22.11$22.02-0.41%$22.25$21.54502,181 shs$1.52 billion05/06/2024$19.66$22.11+12.46%$22.26$19.93895,254 shs$1.53 billion05/03/2024$19.71$19.66-0.25%$20.75$19.63543,492 shs$1.36 billion05/02/2024$20.08$19.71-1.84%$20.44$19.64439,676 shs$1.36 billion05/01/2024$19.89$20.08+0.96%$20.64$19.721.05 million shs$1.39 billion04/30/2024$19.62$19.89+1.38%$20.33$19.33749,599 shs$1.38 billion04/29/2024$19.74$19.62-0.61%$20.02$19.31452,605 shs$1.36 billion04/26/2024$18.93$19.74+4.28%$19.97$18.96753,032 shs$1.37 billion04/25/2024$20.26$18.93-6.56%$19.99$18.20828,667 shs$1.31 billion04/24/2024$21.00$20.26-3.52%$21.26$20.13627,293 shs$1.40 billion04/23/2024$20.79$21.00+1.01%$21.23$20.74556,045 shs$1.45 billion04/22/2024$20.76$20.79+0.14%$20.96$19.89711,336 shs$1.44 billion04/19/2024$20.51$20.76+1.22%$21.05$20.39789,143 shs$1.44 billion04/18/2024$21.60$20.51-5.05%$21.46$20.42760,857 shs$1.15 billion04/17/2024$21.79$21.60-0.87%$22.18$21.57823,317 shs$1.22 billion04/16/2024$21.72$21.79+0.32%$22.04$21.38940,162 shs$1.23 billion04/15/2024$22.18$21.72-2.07%$22.40$21.49757,560 shs$1.22 billion04/12/2024$21.84$22.18+1.56%$22.22$21.39866,401 shs$1.25 billion04/11/2024$21.90$21.84-0.27%$22.42$21.26626,702 shs$1.23 billion04/10/2024$23.74$21.90-7.75%$23.56$21.88817,243 shs$1.23 billion04/09/2024$23.13$23.74+2.64%$23.76$23.01465,217 shs$1.34 billion04/08/2024$23.22$23.13-0.39%$23.46$22.72352,016 shs$1.30 billionBiden Nomination CANCELED? (Ad)The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here.04/05/2024$22.97$23.22+1.09%$23.50$22.01531,811 shs$1.31 billion04/04/2024$23.18$22.97-0.91%$23.89$22.77849,096 shs$1.29 billion04/03/2024$23.38$23.18-0.86%$23.47$22.61680,698 shs$1.31 billion04/02/2024$24.07$23.38-2.87%$24.03$22.96869,827 shs$1.32 billion04/01/2024$25.26$24.07-4.71%$25.28$23.94682,335 shs$1.36 billion03/29/2024$25.26$25.26$25.43$23.71851,564 shs$1.42 billion03/28/2024$24.45$25.26+3.31%$25.43$23.71851,489 shs$1.42 billion03/27/2024$24.39$24.45+0.25%$25.05$23.57990,720 shs$1.38 billion03/26/2024$24.17$24.39+0.91%$25.00$24.15825,461 shs$1.37 billion03/25/2024$25.13$24.17-3.82%$25.90$24.12736,083 shs$1.36 billion03/22/2024$25.94$25.13-3.12%$26.26$24.771.52 million shs$1.41 billion03/21/2024$25.19$25.94+2.98%$26.39$25.271.03 million shs$1.46 billion03/20/2024$25.85$25.19-2.55%$25.85$24.221.56 million shs$1.42 billion03/19/2024$26.84$25.85-3.69%$27.16$25.421.15 million shs$1.46 billion03/18/2024$27.54$26.84-2.54%$27.43$26.061.12 million shs$1.51 billion03/15/2024$27.37$27.54+0.62%$28.24$25.345.14 million shs$1.55 billion03/14/2024$27.97$27.37-2.15%$28.07$24.783.22 million shs$1.54 billion03/13/2024$28.46$27.97-1.72%$29.13$27.671.40 million shs$1.57 billion03/12/2024$29.31$28.46-2.90%$29.57$27.881.47 million shs$1.60 billion03/11/2024$31.18$29.31-6.00%$32.30$28.941.67 million shs$1.65 billion03/08/2024$30.88$31.18+0.97%$32.56$30.602.50 million shs$1.76 billion03/07/2024$30.00$30.88+2.93%$32.09$29.992.32 million shs$1.74 billion03/06/2024$30.52$30.00-1.70%$32.40$28.153.67 million shs$1.69 billion03/05/2024$31.07$30.52-1.77%$31.34$28.142.33 million shs$1.72 billion03/04/2024$27.81$31.07+11.72%$37.00$29.808.45 million shs$1.75 billion03/01/2024$26.99$27.81+3.04%$30.47$27.072.72 million shs$1.55 billion02/29/2024$27.23$26.99-0.88%$29.79$26.932.06 million shs$1.50 billion Related Companies: Enanta Pharmaceuticals Stock Price Chart BridgeBio Pharma Stock Price Chart Grifols Stock Price Chart Cytokinetics Stock Price Chart Apellis Pharmaceuticals Stock Price Chart Madrigal Pharmaceuticals Stock Price Chart Alpine Immune Sciences Stock Price Chart Nuvalent Stock Price Chart Alkermes Stock Price Chart Perrigo Stock Price Chart Receive AKRO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Akero Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AKRO) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyOn June 10, Nvidia makes its next big moveWeiss RatingsUnlock Explosive Gains with This Defense StockBehind the MarketsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe Worst is Yet to Come…Porter & CompanyDems have chosen Biden replacement?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akero Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.